Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127802981 | 12780298 | 1 | I | 20160720 | 0 | 20160923 | 20160923 | DIR | US-FDA-351380 | FDA-CTU | 63.00 | YR | F | N | 73.35000 | KG | 20160923 | N | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127802981 | 12780298 | 1 | PS | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | Y | D | 0 | 30 | DF | COATED TABLET | QD | |||||
| 127802981 | 12780298 | 3 | C | LISINOPRIL HCTZ | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | 0 | ||||||||||||
| 127802981 | 12780298 | 5 | C | VITAMIN C | ASCORBIC ACID | 1 | 0 | ||||||||||||
| 127802981 | 12780298 | 7 | C | MULTIVITAMIN | VITAMINS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127802981 | 12780298 | 1 | Blood pressure measurement |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127802981 | 12780298 | Chest pain | |
| 127802981 | 12780298 | Drug ineffective | |
| 127802981 | 12780298 | Dysuria | |
| 127802981 | 12780298 | Insomnia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127802981 | 12780298 | 1 | 20160625 | 20160825 | 0 |